Patrick Yeramian
Amplyx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Amyotrophic Lateral Sclerosis Research, Reconstructive Surgery and Microvascular Techniques, Biochemical Acid Research Studies
Most-Cited Works
- → A Prospective Study of Microvascular Free-Flap Surgery and Outcome(1998)588 cited
- → Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis(2020)511 cited
- → Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis(2020)174 cited
- → Nucleotide sequence of human rho cDNA clone 12(1987)141 cited
- → A Phase II Trial of Intraluminal Irrigation with Recombinant Human Tissue Factor Pathway Inhibitor to Prevent Thrombosis in Free Flap Surgery(2001)66 cited
- → Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial(2022)64 cited
- → Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain(2016)60 cited
- → Efficacy of DB289 in Thai Patients withPlasmodium vivaxor Acute, UncomplicatedPlasmodiumfalciparumInfections(2005)51 cited
- → N‐ras gene activation in the rd human rhabdomyosarcoma cell line(1985)43 cited